Evotaz Tablet
Product Images NDC 0003-3641

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Evotaz (NDC 0003-3641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ataza Cobic Label.png

Ataza Cobic Label.png
This is a description for a medication called EVOTAZ. Each tablet contains 300mg of atazanavir and 150mg of cobicistat with a total weight of 342 grams. It is manufactured by Bristol-MyersSquibb Company and comes in a bottle containing 30 tablets. The medication should be kept out of the reach of children and at room temperature with the bottle tightly closed. The packaging includes an alert box about medicines that should not be taken with EVOTAZ. The medicine should not be used if the printed label on the bottle is missing or broken.*
FDA Label Image

Atazanavir Chemical Structure (Atazanavir Structure)

FDA Label Image

Cobicistat Chemical Structure (Cobicistat Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.